CEL-SCI Announces That NYSE MKT Approves Plan

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announces that the NYSE MKT (the “Exchange”) has accepted the Company’s plan to bring itself into compliance with the Exchange’s continued listing standards.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC